Stocks股票 / Health Care / INCY
INCY US listed · USD美股 · 美元
Incyte Corporation is an American multinational pharmaceutical company with headquarters in Wilmington, Delaware. The company currently operates manufacturing and R&D locations in North America, Europe, and Asia.因塞特公司是一家总部位于特拉华州威尔明顿的美国跨国制药公司,目前在北美、欧洲和亚洲设有生产和研发基地。
Company news公司新闻
The latest reporting最新报道
One story, with the reporting behind it.将同一事件汇总,保留各来源报道。
The latest call, in context把最新财报放回历史脉络
A synthesized event record across management commentary and recorded metrics. Read as context; verify exact wording in the transcript before relying.综合管理层表述与记录指标形成事件档案。仅供参考;使用前请在电话会原文中核对准确措辞。
Live company record实时公司记录
JavaScript loads the source-bounded event record here. Open Terminal if the live module does not start.JavaScript 会在此加载受来源约束的事件记录。如实时模块未启动,请打开终端。
Continue with full transcript history继续查看完整电话会历史 ↗Price chart价格图表
Technicals技术面
daily bars日线数据 · 2026-10-26Earnings财务业绩
next report下次财报 2026-10-27Estimates being cut预期下调
Beat in 3 of last 4 quarters近 4 季中 3 季超预期
Post-earnings drift: -2.9% (20d)财报后漂移:-2.9%(20日)
EPS surprise vs consensus, last quarters每股收益相对预期的超预期幅度(近几个季度) · average平均 34.3%
Valuation估值
Looks cheap vs sector相对行业偏便宜| Multiple指标 | INCY | Sector median行业中位 | Cheaper than相对便宜 |
|---|---|---|---|
| P/E (trailing)市盈率(历史) | 17.85x | 31.50 | |
| P/B市净率 | 4.44x | 3.57 | |
| P/S市销率 | 4.47x | 3.19 | |
| Earnings yield盈利收益率 | 5.60% | 2.37 | |
| Shareholder yield股东收益率 | 0.00% | 1.83 | |
| EV/EBITDA企业价值/EBITDA | 12.35x | 19.32 |
Financials财务数据
fiscal years财年Leverage杠杆
Capital allocation资本配置
Debt coming due到期债务
FY2018 10-KThe 12-month bucket following fiscal period end 2018-12-31 is not reported. The years below are what the filing did report.文件未披露财年期末 2018-12-31 之后12个月区间的到期金额;下方为其确实披露的年度。
All maturity buckets are measured from fiscal period end 2018-12-31, not from today.所有到期区间均从财年期末 2018-12-31 起算,而非从今天起算。
A cash-flow scenario is unavailable until the filing inputs are verified.报告数据核实前,现金流情景暂不可用。
Capital-need coverage is partial; incomplete or incompatible filing inputs are not combined.资本需求覆盖信息不完整;不会合并不完整或不兼容的报告数据。
Any available cash-flow scenario is context only. Missing or incompatible inputs are not replaced with zero or a financing forecast.可用现金流情景仅供参考;缺失或不兼容的输入不以零值或融资预测替代。
Sources and cash-flow calculation来源与现金流计算
Figures are XBRL facts from one filing — no two years are mixed. Filing数据取自同一份文件中的 XBRL 事实,不跨文件拼接。文件
0001558370-19-000682, period ending报告期截至 2018-12-31, unit单位 USD.
Cache acquired缓存获取时间: 2026-09-26T08:04:07.983286+00:00.
1/6 buckets reported.个区间有披露。
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths— period_mismatchLongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwoLongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree— period_mismatchLongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour— period_mismatchLongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive— period_mismatchLongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive— period_mismatch
Why is it moving为何波动
6 checks · nightly六项检查 · 每晚Options positioning期权持仓
as of last close截至上一收盘Market makers are net short gamma — price moves may amplify做市商净持有负伽玛,价格波动可能被放大
Ownership & smart money持仓与聪明钱
13FInsider activity:内部人动向: -$21.9M net (0 buyers, 6 sellers)-$21.9M 净值(0 买家,6 卖家)
Concentrated ownership集中持仓
| Fund基金 | Grade评级 | Latest move最新动作 | % of book组合占比 | As of截至 |
|---|---|---|---|---|
| Baker Bros. Advisors | A | Holding持有 | 17.5% | 2026-06-30 |
Signal history信号历史
engine events引擎事件Company profile公司档案
Incyte Corporation is an American multinational pharmaceutical company with headquarters in Wilmington, Delaware. The company currently operates manufacturing and R&D locations in North America, Europe, and Asia.因塞特公司是一家总部位于特拉华州威尔明顿的美国跨国制药公司,目前在北美、欧洲和亚洲设有生产和研发基地。
- Inventory build
The whole US universe — S&P 1500 and Russell 2000 — read nightly.覆盖标普1500与罗素2000全部成分股 — 每晚更新解读。
Signals, options positioning, smart-money moves and factor DNA — the same engine that wrote this page covers 2,700+ US stocks.信号、期权持仓、聪明钱动向与因子基因 — 撰写本页的引擎覆盖2700多只美股。
Valuation vs sector估值对比行业
| Multiple指标 | This stock本股 | Sector median行业中位 | Cheaper than相对便宜 |
|---|---|---|---|
| P/E (trailing)市盈率(静态) | 17.9× | 31.5× | 82% |
| Price / Book市净率 | 4.4× | 3.6× | 42% |
| Price / Sales市销率 | 4.5× | 3.2× | 35% |
| EV / EBITDAEV/EBITDA | 12.3× | 19.3× | 82% |
| Earnings yield盈利收益率 | 5.6% | 2.4% | 87% |
| Free-cash-flow yield自由现金流收益率 | 6.2% | 5.2% | 71% |
| Shareholder yield股东综合回报率 | 0.0% | 1.8% | 6% |
Relative strength相对强度
Price history价格历史
| Period周期 | This stock本股 | S&P 500标普500 |
|---|---|---|
| 1 Week近1周 | +2.3% | -0.4% |
| 1 Month近1月 | -7.2% | -1.0% |
| 3 Months近3月 | -1.7% | +3.1% |
| 6 Months近6月 | +22.3% | +7.0% |
| Year to date年初至今 | +14.1% | +12.1% |
| 1 Year近1年 | +29.6% | +14.4% |
Trading information交易信息
Multi-year record多年财务记录
| 20202020 | 20212021 | 20222022 | 20232023 | 20242024 | 20252025 | |
|---|---|---|---|---|---|---|
| Revenue营业收入 | $2.7B | $3.0B | $3.4B | $3.7B | $4.2B | $5.1B |
| EPS每股收益 | $-1.36 | $4.27 | $1.52 | $2.65 | $0.15 | $6.41 |
| Free cash flow自由现金流 | $-312M | $568M | $892M | — | — | — |
| Gross margin毛利率 | 95.1% | 94.9% | 93.9% | 93.1% | 92.6% | 92.8% |
| Net margin净利率 | -11.1% | 31.8% | 10.0% | 16.2% | 0.8% | 25.0% |
| FCF margin自由现金流利润率 | -11.7% | 19.0% | 26.3% | — | — | — |
Latest fiscal year最近财年
Returns & growth回报与增长
Accounting quality checks会计质量检查
- Earnings quality: accruals near the peer median盈利质量:应计利润接近同业中位
- Working capital: inventory +515% vs sales +93% — inventory building, demand risk营运资本:存货 +515% 对销售 +93%——存货积压,需求风险
- Pricing power: gross margin −2.3pts over 6 years定价能力:毛利率 6 年下降 2.3 个百分点
- Capital discipline: assets +27.8% (aggressive expansion)资本纪律:资产 +27.8%(扩张激进)
- Balance sheet: Altman Z 9.8 — safe zone资产负债表:Altman Z 9.8——安全区
Indicator readings指标读数
Timeframe alignment多周期共振
Volatility regime波动状态
Surprise history超预期历史
| Quarter季度 | Reported实际 | Expected预期 | Surprise超预期 |
|---|---|---|---|
| Jun 2026 | $2.80 | $1.76 | +59.1% |
| Mar 2026 | $1.55 | $1.14 | +36.0% |
| Dec 2025 | $1.56 | $1.64 | -4.9% |
| Sep 2025 | $2.03 | $1.38 | +47.1% |
Estimate revisions预期修正
Dealer positioning map做市商持仓地图
Volatility pricing波动率定价
Tracked funds holding it跟踪基金持仓
| Fund基金 | Grade评级 | Latest move最新动作 | % of book组合占比 | Position市值 |
|---|---|---|---|---|
| Baker Bros. Advisors | A | Holding持有 | 17.5% | $3.5B |